查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球急性呼吸窘迫症候群設備市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測
市場調查報告書
商品編碼
1305236

全球急性呼吸窘迫症候群設備市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

Global Acute Respiratory Distress Syndrome Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 135 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2030年，全球急性呼吸窘迫症候群設備市場需求將從2022年的314.32百萬美元達到近669.86百萬美元，2023-2030年的複合年成長率為9.92%。

急性呼吸窘迫症候群（ARDS）設備是指用於為ARDS患者提供呼吸支持的醫療器械和設備。 ARDS是一種嚴重的呼吸系統疾病，可因肺炎、敗血症、創傷或吸入性損傷等各種病症而發生。其特徵是肺部炎症，可導致液體積聚和呼吸困難。 ARDS設備用於幫助ARDS患者更輕鬆有效地呼吸。 ARDS設備包括機械呼吸機、體外膜肺氧合（ECMO）機和高流量鼻插管系統。 ARDS設備對ARDS患者的治療至關重要，因為這種疾病可能危及生命。這些設備有助於改善氧合，減輕肺部的工作負荷，使患者從導致ARDS的潛在疾病中恢復過來。

市場動態：

由於人口老齡化、慢性病發病率上升、敗血症和肺炎發病率升高等因素，ARDS的發病率正在上升，導致對ARDS設備的需求不斷成長，以便為該病患者提供呼吸支持。機械呼吸機和ECMO機等呼吸支持設備的技術進步提高了這些設備的效率和效果，推動了ARDS設備市場的成長。例如，新的通氣模式，如容量控制通氣和壓力控制通氣，可提供更精確的呼吸支持控制。全球老年人口不斷成長，導致對ARDS設備的需求增加，因為老年人更容易患ARDS等呼吸系統疾病。此外，老年人群通常還患有其他合併症，可能需要使用ARDS設備。世界各國政府正在投資於醫學研究、臨床試驗和旨在改善ARDS患者預後的計劃。 COVID-19大流行導致ARDS設備需求激增，特別是機械呼吸機，因為COVID-19嚴重病例可導致ARDS。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構，並評估全球範圍內的競爭吸引力。此外，這些工具還對全球急性呼吸窘迫症候群設備市場的各個細分市場進行了全面評估。急性呼吸窘迫症候群設備行業的成長和趨勢為本研究提供了整體方法。

市場細分：

急性呼吸窘迫症候群設備市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按類型

  • 治療設備（機械呼吸機、PAP、其他）
  • 診斷和監測設備

按最終用戶

  • 醫院
  • 專科中心
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區急性呼吸窘迫症候群設備市場的當前和未來需求。此外，報告還重點分析了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。急性呼吸窘迫症候群設備市場的主要參與者包括koninklijke Plilips NV、Medtronic、Fisher & Paykel Healthcare Limited、Dragerwerk AG & Co.KGaA, Smiths Medical (ICU Medical, Inc.), Hamilton Medical, GE Healthcare, ResMed, Getinge AB, Other.本節包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

目 錄

第一章：前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張（USP）和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章：執行摘要

  • 市場亮點
  • 全球市場概況

第三章：急性呼吸窘迫症候群設備-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第四章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章：COVID-19疫情影響分析

第六章：全球急性呼吸窘迫症候群設備市場分析：按類型分類

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 治療設備（機械呼吸機、PAP、其他）
  • 診斷和監測設備

第七章：全球急性呼吸窘迫症候群設備市場分析：按終端用戶分類

  • 終端用戶概述
  • 歷史和預測數據
  • 按終端用戶分析
  • 醫院
  • 專科中心
  • 其他

第8章：全球急性呼吸窘迫症候群設備市場分析：按地區分類

  • 地區前景
  • 產品介紹
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美地區銷售分析
    • 北美地區各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區各細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲各細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第九章: 急性呼吸窘迫症候群設備企業競爭格局

  • 急性呼吸窘迫症候群設備市場競爭格局
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品上市
  • 其他發展

第10章: 公司概況

  • 頂級公司市場佔有率分析
  • 市場集中度
  • koninklijke Plilips NV
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Medtronic
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Fisher & Paykel Healthcare Limited.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Dragerwerk AG & Co. KGaA
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Smiths Medical (ICU Medical Inc.)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Hamilton Medical
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • GE Healthcare
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • ResMed
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Getinge AB
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Other
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

Product Code: VMR112110668

The global demand for Acute Respiratory Distress Syndrome Devices Market is presumed to reach the market size of nearly USD 669.86 MN by 2030 from USD 314.32 MN in 2022 with a CAGR of 9.92% under the study period 2023 - 2030.

Acute Respiratory Distress Syndrome (ARDS) devices refer to medical devices and equipment used to provide respiratory support to patients suffering from ARDS. ARDS is a severe respiratory condition that can occur in response to various medical conditions, such as pneumonia, sepsis, trauma, or inhalation injury. It is characterized by inflammation in the lungs that can lead to fluid accumulation and difficulty breathing. ARDS devices are used to help patients with ARDS breathe more easily and effectively. Some examples of ARDS devices include mechanical ventilators, extracorporeal membrane oxygenation (ECMO) machines, and high-flow nasal cannula systems. ARDS devices are critical in the treatment of patients with ARDS, as the condition can be life-threatening. These devices can help improve oxygenation and reduce the workload on the lungs, allowing the patient to recover from the underlying condition that led to ARDS.

Market Dynamics:

The incidence of ARDS is increasing due to factors such as ageing populations, increasing rates of chronic diseases, and higher rates of sepsis and pneumonia leading to growing need for ARDS devices to provide respiratory support for patients with this condition. Technological advancements in respiratory support devices, such as mechanical ventilators and ECMO machines, have improved the efficiency and effectiveness of these devices, driving the growth of the ARDS devices market. For example, new ventilation modes, such as volume-controlled ventilation and pressure-controlled ventilation, can provide more precise control of respiratory support. The geriatric population is growing globally, leading to an increased demand for ARDS devices as older adults are more susceptible to respiratory conditions such as ARDS. Additionally, the geriatric population often has other comorbidities that may require the use of ARDS devices. Governments around the world are investing in medical research, clinical trials and initiatives aimed at improving outcomes for patients with ARDS. The COVID-19 pandemic has led to a ARDS devices surge in demand for, particularly mechanical ventilators, as severe cases of COVID-19 can lead to ARDS.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of acute respiratory distress syndrome devices. The growth and trends of acute respiratory distress syndrome devices industry provide a holistic approach to this study.

Market Segmentation:

This section of the acute respiratory distress syndrome devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Therapeutic Devices (Mechanical Ventilators, PAP, Others)
  • Diagnostic & Monitoring Devices

By End User

  • Hospitals
  • Specialty Centers
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Acute Respiratory Distress Syndrome Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the acute respiratory distress syndrome devices market include koninklijke Plilips N.V, Medtronic, Fisher & Paykel Healthcare Limited., Dragerwerk AG & Co. KGaA, Smiths Medical (ICU Medical, Inc.), Hamilton Medical, GE Healthcare, ResMed, Getinge AB, Other. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By End User
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Therapeutic Devices (Mechanical Ventilators, PAP, Others) Historic and Forecast Sales by Regions
  • 6.5 Diagnostic & Monitoring Devices Historic and Forecast Sales by Regions

7 . GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES MARKET ANALYSIS BY END USER

  • 7.1 Overview by End User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End User
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Specialty Centers Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES COMPANIES

  • 9.1. Acute Respiratory Distress Syndrome Devices Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ACUTE RESPIRATORY DISTRESS SYNDROME DEVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. koninklijke Plilips N.V
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Medtronic
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Fisher & Paykel Healthcare Limited.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Dragerwerk AG & Co. KGaA
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Smiths Medical (ICU Medical Inc.)
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Hamilton Medical
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. GE Healthcare
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. ResMed
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Getinge AB
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Other
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Therapeutic Devices (Mechanical Ventilators, PAP, Others) Market Sales by Geography (USD MN)
  • Diagnostic & Monitoring Devices Market Sales by Geography (USD MN)
  • Analysis Market by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Acute Respiratory Distress Syndrome Devices Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Acute Respiratory Distress Syndrome Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Acute Respiratory Distress Syndrome Devices Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Therapeutic Devices (Mechanical Ventilators, PAP, Others) Market Sales by Geography (USD MN)
  • Diagnostic & Monitoring Devices Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Specialty Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.